Health Care: Drugs

Ligand Pharmaceuticals Inc (LGND: NASDAQ)

$72.37 2.07 | 2.94%
03/27/15 - 11:55 AM ET
Company Profile
Price and Volume
Recent Price 70.30
52 Week High 79.61
52 Week Low 41.99
Avg. Daily Vol. (Mil) 0.34
Beta (3 year) 1.40
Share Related Items
Mkt Cap (Mil) 1,380.68
Shares Out (Mil) 19.58
Float (Mil) 15.49
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 7.90
Current Ratio 8.10
LT Debt/ Equity 7.48
Total Debt / Equity 7.58
Valuation Ratios
Price Earnings 125.50
Price/Sales 21.33
Price/Book 52.30
Price/Cash Flow 78.80
Per Share Data
Earnings 0.56
Sales 3.30
Book Value 1.34
Cash Flow 0.89
Business Summary
Ligand Pharmaceuticals Incis a biopharmaceutical company with a business model that is based upon the concept of developing or acquiring royalty revenue generating assets and coupling them with a lean corporate cost structure.
General Information
11119 North Torrey Pines Roa
Suite 200
La Jolla, CA 92037
www.ligand.com
Industry : Drugs
Sector: Health Care
Employees: 19
CEO: Mr. John L. Higgins
Short Interest
Current Month (Mil) 5.41
Previous Month (Mil) 4.85
Short Interest Ratio (Days) 12.90
Management Effectiveness
Return on Equity 41.40
Return on Assets 4.20
Return on Investments 4.90
Profitability
Gross Margin 96.00
EBIT Margin 25.00
Profit Margin 16.90

Portfolios with LGND

Latest LGND Headlines from TheStreet

More Financial News for LGND

Press Releases for LGND

See All Press Releases

Partner Headlines for LGND

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter